Cargando…

A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194

Detalles Bibliográficos
Autores principales:	Bencivenga, Maria, Decimo, Ilaria, Malpeli, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214892/ https://www.ncbi.nlm.nih.gov/pubmed/32411748 http://dx.doi.org/10.21037/atm.2020.03.181

Ejemplares similares

Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy
por: Datlibagi, Azine, et al.
Publicado: (2023)

Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
por: Zou, Hui, et al.
Publicado: (2020)

Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy
por: Ishikawa, Keijiro, et al.
Publicado: (2015)

RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

Exosomes mediate an epithelial‐mesenchymal transition cascade in retinal pigment epithelial cells: Implications for proliferative vitreoretinopathy
por: Zhang, Yao, et al.
Publicado: (2020)

DAPL1 prevents epithelial–mesenchymal transition in the retinal pigment epithelium and experimental proliferative vitreoretinopathy
por: Ma, Xiaoyin, et al.
Publicado: (2023)

Yes‐associated protein is essential for proliferative vitreoretinopathy development via the epithelial‐mesenchymal transition in retinal pigment epithelial fibrosis
por: Zhang, Wei, et al.
Publicado: (2021)

MeCP2‐421‐mediated RPE epithelial‐mesenchymal transition and its relevance to the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy
por: Yang, Shuai, et al.
Publicado: (2021)

Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial–mesenchymal transition in proliferative vitreoretinopathy
por: Pao, Shu-I, et al.
Publicado: (2021)

METTL3 attenuates proliferative vitreoretinopathy and epithelial‐mesenchymal transition of retinal pigment epithelial cells via wnt/β‐catenin pathway
por: Ma, Xinqi, et al.
Publicado: (2021)

Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway
por: Chen, Xiaoyun, et al.
Publicado: (2020)

Proliferative Vitreoretinopathy and Genetic Profile
por: Ghasemi Falavarjani, Khalil
Publicado: (2013)

Proliferative Vitreoretinopathy: A Reappraisal
por: Carpineto, Paolo, et al.
Publicado: (2023)

Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes
por: Telander, David G., et al.
Publicado: (2016)

Proliferative vitreoretinopathy: current and emerging treatments
por: Sadaka, Ama, et al.
Publicado: (2012)

The impact of octreotide in experimental proliferative vitreoretinopathy
por: Evren, Ozge, et al.
Publicado: (2013)

Fulminant proliferative vitreoretinopathy in syphilitic uveitis
por: Queiroz, Rafael de Pinho, et al.
Publicado: (2016)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016)

Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
por: Benner, Jeffrey David, et al.
Publicado: (2019)

Methylation Dynamics of RASSF1A and Its Impact on Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2019)

Non-viral gene therapy using RNA interference with PDGFR-α mediated epithelial-mesenchymal transformation for proliferative vitreoretinopathy
por: Wang, Jiahao, et al.
Publicado: (2023)

Subretinal Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy
por: Dalma-Weiszhausz, Jose, et al.
Publicado: (2012)

Evaluation of retinectomy in the treatment of severe proliferative vitreoretinopathy
por: Mendes, Thaís Sousa, et al.
Publicado: (2015)

Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
por: Takkar, Brijesh, et al.
Publicado: (2017)

Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy
por: Kaneko, Hiroki, et al.
Publicado: (2017)

Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development
por: Chaudhary, Rishika, et al.
Publicado: (2020)

Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review
por: Dai, Ying, et al.
Publicado: (2020)

TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
por: Wang, Victor, et al.
Publicado: (2022)

Using Advanced Bioinformatics Tools to Identify Novel Therapeutic Candidates for Proliferative Vitreoretinopathy
por: Xie, Edward F., et al.
Publicado: (2023)

Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2022)

MicroRNA-194 modulates epithelial–mesenchymal transition in human colorectal cancer metastasis
por: Cai, Hong-Ke, et al.
Publicado: (2017)

Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy
por: Zhang, W, et al.
Publicado: (2012)

Mechanisms of Inflammation in Proliferative Vitreoretinopathy: From Bench to Bedside
por: Moysidis, Stavros N., et al.
Publicado: (2012)

Aquaporin-1 Expression in Proliferative Vitreoretinopathy and in Epiretinal Membranes
por: Motulsky, Elie, et al.
Publicado: (2014)

The proteomic profile of a mouse model of proliferative vitreoretinopathy
por: Márkus, Bernadett, et al.
Publicado: (2017)

Outcomes of Vitrectomy in Pediatric Retinal Detachment with Proliferative Vitreoretinopathy
por: Rejdak, Robert, et al.
Publicado: (2017)

Commentary: Management of proliferative vitreoretinopathy in recurrent retinal detachment
por: Babu, Naresh, et al.
Publicado: (2020)

Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice
por: Chen, Shun-Hua, et al.
Publicado: (2021)

Infographic: Slow-release dexamethasone in proliferative vitreoretinopathy (PVR)
por: Mostafa, I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2e3op8bjmkomc6s90c5ri9kktv